Manjiang Li
Overview
Explore the profile of Manjiang Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li M, Ding W, Wang Y, Ma Y, Du F
Environ Sci Pollut Res Int
. 2022 Oct;
30(7):17166-17178.
PMID: 36192587
Pancreatic cancer (PC) is one of the most common malignant tumors in the world with a poor prognosis. There were limited studies investigating the genetic signatures associated with inflammatory responses,...
2.
Ding W, Wang Y, Ma Y, Lin L, Li M
Dis Markers
. 2022 Sep;
2022:3839480.
PMID: 36061357
Pancreatic cancer (PC) has a dismal prognosis despite advancing scientific and technological knowledge. The exploration of novel genes is critical to improving current therapeutic measures. This research is aimed at...
3.
Zhao L, Chen X, Li M, Deng H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
. 2021 Jul;
38(7):690-693.
PMID: 34247380
Objective: To explore the phenotypic and genetic characteristics of acute megakaryoblastic leukemia (AMKL) in young children accompany by WT1, MLL-PTD and EVI1, in order to improve the diagnosis level of...
4.
Wang S, Shi H, Liu T, Li M, Zhou S, Qiu X, et al.
Hepatobiliary Surg Nutr
. 2021 Apr;
10(2):172-179.
PMID: 33898558
Background: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer worldwide. Although many studies have focused on oncogene characteristics, the genomic landscape of Chinese HCC patients has...
5.
Qiu X, Li M, Wu L, Xin Y, Mu S, Li T, et al.
Cancer Manag Res
. 2020 Sep;
12:7983-7992.
PMID: 32943932
Objective: To investigate the effects of fatigue on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib. Patients And Methods: A retrospective analysis of 182 cases of patients...
6.
Zhou S, Wang Z, Li M, Wu L
Biomed Res Int
. 2019 Oct;
2019:6959637.
PMID: 31662990
Aim: Little is known about the association between cancer antigen 125 (MUC16/CA125) concentrations and tumor diameter of patients with hepatocellular carcinoma (HCC) and low AFP levels. To fill this gap...
7.
Li M, Wang Z, Cao J, Han B, Zou H, Zang Y, et al.
Eur J Surg Oncol
. 2019 Apr;
45(9):1684-1690.
PMID: 31027944
Background: Management of recurrent hepatocellular cancer (HCC) after liver resection is challenging, with unsatisfactory long-term patient outcomes. Liver re-resection, in theory, is a good treatment option. We therefore studied prognosis...